{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T03:55:14Z","timestamp":1791258914008,"version":"4.1.0"},"reference-count":63,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T00:00:00Z","timestamp":1788480000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T00:00:00Z","timestamp":1788739200000},"content-version":"vor","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006492","name":"Division of Intramural Research, National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["AI075045, AI173557, AI089674"],"award-info":[{"award-number":["AI075045, AI173557, AI089674"]}],"id":[{"id":"10.13039\/100006492","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","award":["INV-037316"],"award-info":[{"award-number":["INV-037316"]}],"id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["RIA2018SD-2306 - PAMAfrica"],"award-info":[{"award-number":["RIA2018SD-2306 - PAMAfrica"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Commun"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Mutations in the\n                    <jats:italic>Plasmodium falciparum<\/jats:italic>\n                    genes,\n                    <jats:italic>pfdhfr<\/jats:italic>\n                    and\n                    <jats:italic>pfdhps<\/jats:italic>\n                    , drive antifolate resistance and threaten malaria control in regions where sulfadoxine-pyrimethamine (SP) is the primary chemoprevention strategy. The spatial patterns and evolutionary dynamics of these mutations in high-transmission settings remain incompletely understood. Here we genotyped 11 resistance-associated mutations in\n                    <jats:italic>pfdhfr<\/jats:italic>\n                    and\n                    <jats:italic>pfdhps<\/jats:italic>\n                    in 4,725\u2009\n                    <jats:italic>P. falciparum<\/jats:italic>\n                    isolates collected from 16 Ugandan health facilities as part of annual surveillance between 2016 and 2022. Notably, we show that the frequency of PfDHFR I164L, which confers higher pyrimethamine resistance, increased over time from 19.4% to 32.4%. Using identity-by-descent, haplotype structure, and extended haplotype homozygosity analyses, we show that PfDHFR I164L is present on multiple haplotype backgrounds and undergoes localised expansions, without detectable signatures of recent positive selection at all but one site. Our results suggest that the evolution of antifolate resistance, driven by PfDHFR I164L, is spatially heterogeneous and complex in regions that primarily use SP chemoprevention programmes.\n                  <\/jats:p>","DOI":"10.1038\/s41467-026-76826-4","type":"journal-article","created":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T18:54:12Z","timestamp":1788548052000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Multiple local PfDHFR I164L haplotype expansions drive Plasmodium falciparum antifolate resistance in Uganda"],"prefix":"10.1038","volume":"17","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0489-4692","authenticated-orcid":false,"given":"Victor","family":"Asua","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karamoko","family":"Niar\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreeya","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Legac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Tukwasibwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Katairo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis E.","family":"Bohissou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M.","family":"Crudale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfred","family":"Simkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry","family":"Mulondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam L.","family":"Nsobya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8605-2001","authenticated-orcid":false,"given":"Isaac","family":"Ssewanyana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grant","family":"Dorsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6899-8204","authenticated-orcid":false,"given":"Jeffrey A.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moses R.","family":"Kamya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adoke","family":"Yeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J.","family":"Rosenthal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steffen","family":"Borrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9984-8030","authenticated-orcid":false,"given":"Melissa D.","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,9,4]]},"reference":[{"key":"76826_CR1","unstructured":"World Health Organization. World Malaria Report 2025: Addressing the Threat of Antimalarial Drug Resistance (WHO, 2025)."},{"key":"76826_CR2","unstructured":"World Health Organization. World Malaria Report 2016 (WHO, 2016)."},{"key":"76826_CR3","unstructured":"World Health Organization. World Malaria Report 2024: Addressing Inequity in the Global Malaria Response (WHO, 2024)."},{"key":"76826_CR4","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1016\/S0140-6736(22)02535-1","volume":"401","author":"M Madanitsa","year":"2023","unstructured":"Madanitsa, M. et al. Effect of monthly intermittent preventive treatment with dihydroartemisinin\u2013piperaquine with and without azithromycin versus monthly sulfadoxine\u2013pyrimethamine on adverse pregnancy outcomes in Africa: a double-blind randomised, partly placebo-controlled trial.  Lancet 401, 1020\u20131036 (2023).","journal-title":"Lancet"},{"key":"76826_CR5","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S1473-3099(24)00746-1","volume":"25","author":"A Nuwa","year":"2025","unstructured":"Nuwa, A. et al. Effectiveness of sulfadoxine-pyrimethamine plus amodiaquine and dihydroartemisinin-piperaquine for seasonal malaria chemoprevention in Uganda: a three-arm, open-label, non-inferiority and superiority, cluster-randomised, controlled trial. Lancet Infect. Dis. 25, 726\u2013736 (2025).","journal-title":"Lancet Infect. Dis."},{"key":"76826_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-024-05229-x","volume":"24","author":"K Baker","year":"2025","unstructured":"Baker, K. et al. Phase one of a hybrid effectiveness-implementation study to assess the feasibility, acceptability and effectiveness of implementing seasonal malaria chemoprevention in Nampula Province, Mozambique. Malar. J. 24, 1\u201318 (2025).","journal-title":"Malar. J."},{"key":"76826_CR7","doi-asserted-by":"crossref","unstructured":"Nuwa, A. et al. A non-randomized controlled trial to assess the protective effect of SMC in the context of high parasite resistance in Uganda. Malar. J. 22, 63 (2023).","DOI":"10.1186\/s12936-023-04488-4"},{"key":"76826_CR8","doi-asserted-by":"publisher","first-page":"2682","DOI":"10.1093\/molbev\/msq160","volume":"27","author":"KM Brown","year":"2010","unstructured":"Brown, K. M. et al. Compensatory Mutations Restore Fitness during the Evolution of Dihydrofolate Reductase. Mol. Biol. Evol. 27, 2682\u20132690 (2010).","journal-title":"Mol. Biol. Evol."},{"key":"76826_CR9","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/0035-9203(54)90038-3","volume":"48","author":"PG Shute","year":"1954","unstructured":"Shute, P. G. & Maryon, M. The effect of pyrimethamine (daraprim) on the gametocytes and oocysts of Plasmodium falciparum and Plasmodium vivax. Trans. R. Soc. Trop. Med. Hyg. 48, 50\u201352 (1954).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"76826_CR10","doi-asserted-by":"publisher","first-page":"325","DOI":"10.4269\/ajtmh.1984.33.325","volume":"33","author":"JD Chulay","year":"1984","unstructured":"Chulay, J. D., Watkins, W. M. & Sixsmith, D. G. Synergistic antimalarial activity of pyrimethamine and sulfadoxine against Plasmodium falciparum in vitro. Am. J. Trop. Med. Hyg. 33, 325\u2013330 (1984).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"76826_CR11","doi-asserted-by":"publisher","first-page":"9114","DOI":"10.1073\/pnas.85.23.9114","volume":"85","author":"DS Peterson","year":"1988","unstructured":"Peterson, D. S., Walliker, D. & Wellems, T. E. Evidence that a point mutation in dihydrofolate reductase-thymidylate synthase confers resistance to pyrimethamine in falciparum malaria. Proc. Natl. Acad. Sci. USA 85, 9114\u20139118 (1988).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76826_CR12","doi-asserted-by":"publisher","first-page":"12025","DOI":"10.1073\/pnas.0905922106","volume":"106","author":"ER Lozovsky","year":"2009","unstructured":"Lozovsky, E. R. et al. Stepwise acquisition of pyrimethamine resistance in the malaria parasite. Proc. Natl. Acad. Sci. USA 106, 12025\u201312030 (2009).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76826_CR13","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1093\/infdis\/jit415","volume":"209","author":"T Mita","year":"2014","unstructured":"Mita, T. et al. Ordered accumulation of mutations conferring resistance to sulfadoxine-pyrimethamine in the Plasmodium falciparum parasite. J. Infect. Dis. 209, 130\u2013139 (2014).","journal-title":"J. Infect. Dis."},{"key":"76826_CR14","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S0035-9203(01)90331-1","volume":"95","author":"MR Kamya","year":"2001","unstructured":"Kamya, M. R. et al. The comparative efficacy of chloroquine and sulfadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. Trans. R. Soc. Trop. Med. Hyg. 95, 50\u201355 (2001).","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"76826_CR15","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/S0140-6736(01)05557-X","volume":"358","author":"SG Staedke","year":"2001","unstructured":"Staedke, S. G. et al. Amodiaquine, sulfadoxine\/pyrimethamine, and combination therapy for treatment of uncomplicated falciparum malaria in Kampala, Uganda: a randomised trial. Lancet 358, 368\u2013374 (2001).","journal-title":"Lancet"},{"key":"76826_CR16","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1093\/cid\/civ881","volume":"62","author":"M Desai","year":"2016","unstructured":"Desai, M. et al. Impact of sulfadoxine-pyrimethamine resistance on effectiveness of intermittent preventive therapy for Malaria in pregnancy at clearing infections and preventing low birth weight. Clin. Infect. Dis. 62, 323\u2013333 (2016).","journal-title":"Clin. Infect. Dis."},{"key":"76826_CR17","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1093\/infdis\/jiab435","volume":"225","author":"O Kreutzfeld","year":"2022","unstructured":"Kreutzfeld, O. et al. Decreased susceptibility to dihydrofolate reductase inhibitors associated with genetic polymorphisms in Ugandan Plasmodium falciparum isolates. J. Infect. Dis. 225, 696\u2013704 (2022).","journal-title":"J. Infect. Dis."},{"key":"76826_CR18","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.1004376","volume":"21","author":"A Mousa","year":"2024","unstructured":"Mousa, A. et al. Measuring protective efficacy and quantifying the impact of drug resistance: a novel malaria chemoprevention trial design and methodology. PLoS Med. 21, e1004376 (2024).","journal-title":"PLoS Med."},{"key":"76826_CR19","doi-asserted-by":"publisher","DOI":"10.1186\/s12936-015-0909-7","volume":"14","author":"V Braun","year":"2015","unstructured":"Braun, V. et al. Lack of effect of intermittent preventive treatment for malaria in pregnancy and intense drug resistance in western Uganda. Malar. J. 14, 372 (2015).","journal-title":"Malar. J."},{"key":"76826_CR20","doi-asserted-by":"publisher","first-page":"3995","DOI":"10.1128\/AAC.04961-14","volume":"59","author":"NW Lucchi","year":"2015","unstructured":"Lucchi, N. W. et al. Increasing prevalence of a novel triple-mutant dihydropteroate synthase genotype in Plasmodium falciparum in Western Kenya. Antimicrob. Agents Chemother. 59, 3995 (2015).","journal-title":"Antimicrob. Agents Chemother."},{"key":"76826_CR21","doi-asserted-by":"publisher","first-page":"985","DOI":"10.1371\/journal.pcbi.1010317","volume":"18","author":"JA Flegg","year":"2022","unstructured":"Flegg, J. A. et al. Spatiotemporal spread of Plasmodium falciparum mutations for resistance to sulfadoxine-pyrimethamine across Africa, 1990\u20132020. PLoS Comput. Biol. 18, 985\u2013994 (2022).","journal-title":"PLoS Comput. Biol."},{"key":"76826_CR22","doi-asserted-by":"crossref","unstructured":"Juliano, J. J. et al. Prevalence of mutations associated with artemisinin partial resistance and sulfadoxine\u2013pyrimethamine resistance in 13 regions in Tanzania in 2021: a cross-sectional survey. Lancet Microbe 5, 100920 (2024).","DOI":"10.1016\/S2666-5247(24)00160-5"},{"key":"76826_CR23","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1128\/AAC.00498-09","volume":"54","author":"C Karema","year":"2010","unstructured":"Karema, C. et al. Molecular correlates of high-level antifolate resistance in Rwandan children with Plasmodium falciparum malaria. Antimicrob. Agents Chemother. 54, 477\u2013483 (2010).","journal-title":"Antimicrob. Agents Chemother."},{"key":"76826_CR24","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1093\/infdis\/jiy223","volume":"218","author":"O Aydemir","year":"2018","unstructured":"Aydemir, O. et al. Drug-Resistance and population structure of Plasmodium falciparum across the democratic Republic of Congo using high-Throughput molecular inversion probes. J. Infect. Dis. 218, 946\u2013955 (2018).","journal-title":"J. Infect. Dis."},{"key":"76826_CR25","doi-asserted-by":"crossref","unstructured":"Asua, V. et al. Changing prevalence of potential mediators of aminoquinoline, antifolate, and artemisinin resistance across Uganda. J. Infect. Dis. 223, 985\u2013994 (2021).","DOI":"10.1093\/infdis\/jiaa687"},{"key":"76826_CR26","doi-asserted-by":"crossref","unstructured":"Andriantsoanirina, V. et al. In vitro susceptibility to pyrimethamine of DHFR I164L single mutant Plasmodium falciparum. Malar. J. 10, 283 (2011).","DOI":"10.1186\/1475-2875-10-283"},{"key":"76826_CR27","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/S1473-3099(18)30732-1","volume":"19","author":"AM van Eijk","year":"2019","unstructured":"van Eijk, A. M. et al. Effect of Plasmodium falciparum sulfadoxine-pyrimethamine resistance on the effectiveness of intermittent preventive therapy for malaria in pregnancy in Africa: a systematic review and meta-analysis. Lancet Infect. Dis. 19, 546\u2013556 (2019).","journal-title":"Lancet Infect. Dis."},{"key":"76826_CR28","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.pt.2013.08.002","volume":"29","author":"I Naidoo","year":"2013","unstructured":"Naidoo, I. & Roper, C. Mapping \u2018partially resistant\u2019, \u2018fully resistant\u2019, and \u2018super resistant\u2019 malaria. Trends Parasitol. 29, 505\u2013515 (2013). Preprint at.","journal-title":"Trends Parasitol."},{"key":"76826_CR29","doi-asserted-by":"crossref","unstructured":"Okell, L. C., Griffin, J. T. & Roper, C. Mapping sulphadoxine-pyrimethamine-resistant Plasmodium falciparum malaria in infected humans and in parasite populations in Africa. Sci. Rep. 7, 7389 (2017).","DOI":"10.1038\/s41598-017-06708-9"},{"key":"76826_CR30","doi-asserted-by":"publisher","first-page":"e1007279","DOI":"10.1371\/journal.pgen.1007279","volume":"14","author":"L Henden","year":"2018","unstructured":"Henden, L., Lee, S., Mueller, I., Barry, A. & Bahlo, M. Identity-by-descent analyses for measuring population dynamics and selection in recombining pathogens. PLoS Genet. 14, e1007279 (2018).","journal-title":"PLoS Genet."},{"key":"76826_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-019-2880-1","volume":"18","author":"SK Tessema","year":"2019","unstructured":"Tessema, S. K. et al. Applying next-generation sequencing to track falciparum malaria in sub-Saharan Africa. Malar. J. 18, 1\u20139 (2019).","journal-title":"Malar. J."},{"key":"76826_CR32","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/j.pt.2025.03.012","volume":"41","author":"B Guo","year":"2025","unstructured":"Guo, B., Rowley, E., O\u2019Connor, T. D. & Takala-Harrison, S. Potential and pitfalls of using identity-by-descent for malaria genomic surveillance. Trends Parasitol. 41, 387\u2013400 (2025).","journal-title":"Trends Parasitol."},{"key":"76826_CR33","doi-asserted-by":"crossref","unstructured":"Guo, B., Takala-Harrison, S. & O\u2019Connor, T. D. Benchmarking and optimization of methods for the detection of identity-by-descent in high-recombining Plasmodium falciparum genomes. Elife 14, RP101924 (2025).","DOI":"10.7554\/eLife.101924.3"},{"key":"76826_CR34","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s43856-024-00498-8","volume":"4","author":"AA Fola","year":"2024","unstructured":"Fola, A. A. et al. Genomics reveals heterogeneous Plasmodium falciparum transmission and selection signals in Zambia. Commun. Med. 4, 67 (2024).","journal-title":"Commun. Med."},{"key":"76826_CR35","doi-asserted-by":"crossref","unstructured":"Holzschuh, A. et al. Multiplexed ddPCR-amplicon sequencing reveals isolated Plasmodium falciparum populations amenable to local elimination in Zanzibar, Tanzania. Nat. Commun. 14, 3699 (2023).","DOI":"10.1038\/s41467-023-39417-1"},{"key":"76826_CR36","first-page":"297","volume":"5","author":"BG Brhane","year":"2025","unstructured":"Brhane, B. G. et al. Rising prevalence of Plasmodium falciparum artemisinin partial resistance mutations in Ethiopia. Commun. Med. 2025 5 5, 297 (2025).","journal-title":"Commun. Med. 2025 5"},{"key":"76826_CR37","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1056\/NEJMoa2211803","volume":"389","author":"MD Conrad","year":"2023","unstructured":"Conrad, M. D. et al. Evolution of partial resistance to artemisinins in malaria parasites in Uganda. N. Engl. J. Med. 389, 722\u2013732 (2023).","journal-title":"N. Engl. J. Med."},{"key":"76826_CR38","doi-asserted-by":"publisher","unstructured":"Katairo, T. et al. Sustained high prevalence of multiple antimalarial drug resistance markers in Uganda in 2023-2024. Antimicrob. Agents Chemother. e0036126. https:\/\/doi.org\/10.1128\/aac.00361-26 (2026).","DOI":"10.1128\/aac.00361-26"},{"key":"76826_CR39","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.01818-18","volume":"63","author":"V Asua","year":"2019","unstructured":"Asua, V. et al. Changing molecular markers of antimalarial drug sensitivity across Uganda. Antimicrob. Agents Chemother. 63, e01818-18 (2019).","journal-title":"Antimicrob. Agents Chemother."},{"key":"76826_CR40","doi-asserted-by":"publisher","DOI":"10.1186\/1475-2875-11-134","volume":"11","author":"NC Iriemenam","year":"2012","unstructured":"Iriemenam, N. C. et al. Temporal trends of sulphadoxine-pyrimethamine (SP) drug-resistance molecular markers in Plasmodium falciparum parasites from pregnant women in western Kenya. Malar. J. 11, 134 (2012).","journal-title":"Malar. J."},{"key":"76826_CR41","doi-asserted-by":"publisher","first-page":"1598","DOI":"10.1086\/587845","volume":"197","author":"C Lynch","year":"2008","unstructured":"Lynch, C. et al. Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda. J. Infect. Dis. 197, 1598\u20131604 (2008).","journal-title":"J. Infect. Dis."},{"key":"76826_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12936-020-03514-z","volume":"19","author":"A Epstein","year":"2020","unstructured":"Epstein, A. et al. Estimating malaria incidence from routine health facility-based surveillance data in Uganda. Malar. J. 19, 1\u201311 (2020).","journal-title":"Malar. J."},{"key":"76826_CR43","doi-asserted-by":"crossref","unstructured":"Kigozi, S. P. et al. Spatial-temporal patterns of malaria incidence in Uganda using HMIS data from 2015 to 2019. BMC Public Health 20, 1913 (2020).","DOI":"10.1186\/s12889-020-10007-w"},{"key":"76826_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/gb-2011-12-4-r33","volume":"12","author":"H Jiang","year":"2011","unstructured":"Jiang, H. et al. High recombination rates and hotspots in a Plasmodium falciparum genetic cross. Genome Biol. 12, R33 (2011).","journal-title":"Genome Biol."},{"key":"76826_CR45","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1086\/504687","volume":"194","author":"AM McCollum","year":"2006","unstructured":"McCollum, A. M. et al. Antifolate resistance in Plasmodium falciparum: multiple origins and identification of novel dhfr alleles. J. Infect. Dis. 194, 189\u2013197 (2006).","journal-title":"J. Infect. Dis."},{"key":"76826_CR46","unstructured":"World Health Organization. WHO guidelines for malaria. https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/366432\/WHO-UCN-GMP-2023.01-eng.pdf?sequence=1 (2023)."},{"key":"76826_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0020190","volume":"2","author":"A Yeka","year":"2005","unstructured":"Yeka, A. et al. Artemisinin versus nonartemisinin combination therapy for uncomplicated malaria: randomized clinical trials from four sites in Uganda. PLoS Med. 2, e190 (2005).","journal-title":"PLoS Med."},{"key":"76826_CR48","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.1016\/S0140-6736(01)06201-8","volume":"358","author":"JK Iyer","year":"2001","unstructured":"Iyer, J. K., Milhous, W. K., Cortese, J. F., Kublin, J. G. & Plowe, C. V. Plasmodium falciparum cross-resistance between trimethoprim and pyrimethamine. Lancet 358, 1066\u20131067 (2001).","journal-title":"Lancet"},{"key":"76826_CR49","doi-asserted-by":"publisher","first-page":"586","DOI":"10.4269\/ajtmh.2003.68.586","volume":"68","author":"I Khalil","year":"2003","unstructured":"Khalil, I. et al. Dihydrofolate reductase and dihydropteroate synthase genotypes associated with in vitro resistance of Plasmodium falciparum to pyrimethamine, trimethoprim, sulfadoxine, and sulfamethoxazole. Am. J. Trop. Med. Hyg. 68, 586\u2013589 (2003).","journal-title":"Am. J. Trop. Med. Hyg."},{"key":"76826_CR50","unstructured":"Uganda Bureau of Statistics. Uganda Malaria Indicator Survey 2018, 31\u201333 (Uganda Bureau of Statistics, 2019)."},{"key":"76826_CR51","doi-asserted-by":"publisher","first-page":"832","DOI":"10.1038\/nature01140","volume":"419","author":"PC Sabeti","year":"2002","unstructured":"Sabeti, P. C. et al. Detecting recent positive selection in the human genome from haplotype structure. Nature 419, 832\u2013837 (2002).","journal-title":"Nature"},{"key":"76826_CR52","doi-asserted-by":"publisher","first-page":"20129","DOI":"10.1073\/pnas.1319857110","volume":"110","author":"HH Chang","year":"2013","unstructured":"Chang, H. H. et al. Malaria life cycle intensifies both natural selection and random genetic drift. Proc. Natl. Acad. Sci. Usa. 110, 20129\u201320134 (2013).","journal-title":"Proc. Natl. Acad. Sci. Usa."},{"key":"76826_CR53","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1016\/j.meegid.2016.06.001","volume":"43","author":"P Salgueiro","year":"2016","unstructured":"Salgueiro, P., Vicente, J. L., Figueiredo, R. C. & Pinto, J. Genetic diversity and population structure of Plasmodium falciparum over space and time in an African archipelago. Infect., Genet. Evol. 43, 252\u2013260 (2016).","journal-title":"Infect., Genet. Evol."},{"key":"76826_CR54","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1073\/pnas.94.4.1124","volume":"94","author":"W Sirawaraporn","year":"1997","unstructured":"Sirawaraporn, W., Sathitkul, T., Sirawaraporn, R., Yuthavong, Y. & Santi, D. V. Antifolate-resistant mutants of Plasmodium falciparum dihydrofolate reductase. Proc. Natl. Acad. Sci. USA 94, 1124\u20131129 (1997).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"76826_CR55","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1046\/j.1365-2958.1999.01437.x","volume":"32","author":"P Wang","year":"1999","unstructured":"Wang, P., Brobey, R. K. B., Horii, T., Sims, P. F. G. & Hyde, J. E. Utilization of exogenous folate in the human malaria parasite Plasmodium falciparum and its critical role in antifolate drug synergy. Mol. Microbiol. 32, 1254\u20131262 (1999).","journal-title":"Mol. Microbiol."},{"key":"76826_CR56","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1126\/science.1098876","volume":"305","author":"C Roper","year":"2004","unstructured":"Roper, C. et al. Intercontinental spread of pyrimethamine-resistant malaria. Science305, 1124 (2004).","journal-title":"Science"},{"key":"76826_CR57","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1093\/molbev\/msg162","volume":"20","author":"S Nair","year":"2003","unstructured":"Nair, S. et al. A selective sweep driven by pyrimethamine treatment in southeast asian malaria parasites. Mol. Biol. Evol. 20, 1526\u20131536 (2003).","journal-title":"Mol. Biol. Evol."},{"key":"76826_CR58","doi-asserted-by":"crossref","unstructured":"Pearce, R. J. et al. Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria. PLoS Med. 6, e1000055 (2009).","DOI":"10.1371\/journal.pmed.1000055"},{"key":"76826_CR59","doi-asserted-by":"crossref","unstructured":"Teyssier, N. B. et al. Optimization of whole-genome sequencing of Plasmodium falciparum from low-density dried blood spot samples. Malar. J. 20, 116 (2021).","DOI":"10.1186\/s12936-021-03630-4"},{"key":"76826_CR60","doi-asserted-by":"crossref","unstructured":"Verity, R. et al. The impact of antimalarial resistance on the genetic structure of Plasmodium falciparum in the DRC. Nat. Commun. 11, 2107 (2020).","DOI":"10.1038\/s41467-020-15779-8"},{"key":"76826_CR61","doi-asserted-by":"crossref","unstructured":"Niar\u00e9, K. et al. Highly multiplexed molecular inversion probe panel in Plasmodium falciparum targeting common SNPs approximates whole-genome sequencing assessments for selection and relatedness. Front. Genet. 16, 1526049 (2025).","DOI":"10.3389\/fgene.2025.1526049"},{"key":"76826_CR62","doi-asserted-by":"crossref","unstructured":"Guo, B., Schaffner, S. F., Taylor, A. R., O\u2019Connor, T. D. & Takala-Harrison, S. hmmibd-rs: an enhanced hmmIBD implementation for parallelizable identity-by-descent detection from large-scale Plasmodium genomic data. Malar. J. 25, 110 (2025).","DOI":"10.21203\/rs.3.rs-7004070\/v1"},{"key":"76826_CR63","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1111\/1755-0998.12634","volume":"17","author":"M Gautier","year":"2017","unstructured":"Gautier, M., Klassmann, A. & Vitalis, R. rehh 2.0: a reimplementation of the R package rehh to detect positive selection from haplotype structure. Mol. Ecol. Resour. 17, 78\u201390 (2017).","journal-title":"Mol. Ecol. Resour."}],"container-title":["Nature Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76826-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76826-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76826-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T06:02:26Z","timestamp":1788847346000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41467-026-76826-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,4]]},"references-count":63,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["76826"],"URL":"https:\/\/doi.org\/10.1038\/s41467-026-76826-4","relation":{},"ISSN":["2041-1723"],"issn-type":[{"value":"2041-1723","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,4]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflicts of interest. The funders did not play a role in the design, implementation, analysis and reporting of the study results.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}],"article-number":"9552"}}